290 related articles for article (PubMed ID: 36082857)
1. Combination Therapy for the Treatment of Alzheimer's Disease: Recent Progress and Future Prospects.
Shirbhate E; Patel VK; Tiwari P; Kore R; Veerasamy R; Mishra A; Rajak H
Curr Top Med Chem; 2022; 22(22):1849-1867. PubMed ID: 36082857
[TBL] [Abstract][Full Text] [Related]
2. Combination Drug Therapy for the Management of Alzheimer's Disease.
Kabir MT; Uddin MS; Mamun AA; Jeandet P; Aleya L; Mansouri RA; Ashraf GM; Mathew B; Bin-Jumah MN; Abdel-Daim MM
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380758
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapeutic combinations for the treatment of Alzheimer's disease.
Nagata T; Shinagawa S; Nakajima S; Noda Y; Mimura M
Expert Opin Pharmacother; 2022 Apr; 23(6):727-737. PubMed ID: 35230200
[TBL] [Abstract][Full Text] [Related]
4. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
5. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
Sahoo AK; Dandapat J; Dash UC; Kanhar S
J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
[TBL] [Abstract][Full Text] [Related]
7. Cognitive symptoms of Alzheimer's disease: clinical management and prevention.
Joe E; Ringman JM
BMJ; 2019 Dec; 367():l6217. PubMed ID: 31810978
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacology of Alzheimer's disease: where do we go from here?].
Sellal F; Nieoullon A; Michel G; Michel BF; Lacomblez L; Geerts H; Delini-Stula A; Bentué-Ferrer D; Bordet R; Allain H
Therapie; 2005; 60(2):89-107. PubMed ID: 15969312
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging therapies for Alzheimer's disease.
Nygaard HB
Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
[TBL] [Abstract][Full Text] [Related]
10. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies for Alzheimer's disease in clinical trials.
Godyń J; Jończyk J; Panek D; Malawska B
Pharmacol Rep; 2016 Feb; 68(1):127-38. PubMed ID: 26721364
[TBL] [Abstract][Full Text] [Related]
12. Reimagining cholinergic therapy for Alzheimer's disease.
Giacobini E; Cuello AC; Fisher A
Brain; 2022 Jul; 145(7):2250-2275. PubMed ID: 35289363
[TBL] [Abstract][Full Text] [Related]
13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
Parnetti L; Senin U; Mecocci P
Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
[TBL] [Abstract][Full Text] [Related]
14. Targets, trials and tribulations in Alzheimer therapeutics.
Gharat R; Dixit G; Khambete M; Prabhu A
Eur J Pharmacol; 2024 Jan; 962():176230. PubMed ID: 38042464
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Alzheimer's disease: current status and new perspectives.
Scarpini E; Scheltens P; Feldman H
Lancet Neurol; 2003 Sep; 2(9):539-47. PubMed ID: 12941576
[TBL] [Abstract][Full Text] [Related]
17. Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease.
Li J; Haj Ebrahimi A; Ali AB
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791206
[TBL] [Abstract][Full Text] [Related]
18. Drug treatments in Alzheimer's disease.
Briggs R; Kennelly SP; O'Neill D
Clin Med (Lond); 2016 Jun; 16(3):247-53. PubMed ID: 27251914
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach.
Morató X; Pytel V; Jofresa S; Ruiz A; Boada M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012569
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging drug treatment options for Alzheimer's disease: a systematic review.
Herrmann N; Chau SA; Kircanski I; Lanctôt KL
Drugs; 2011 Oct; 71(15):2031-65. PubMed ID: 21985169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
